Health Care · Pharmaceutical Preparations · Nasdaq · CIK 34956 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $14.82Day −6.20%Mkt cap $581M1Y +138.3%Off 52W high −23.6%Vol (1Y) 76.2%
Daily closing price, split-adjusted to the current basis; 3y shown of 5,293 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest5.2% of sh out |
| Days to cover1.4d |
| 13F net flow (QoQ)+15.12% |
| Top-10 13F concentration56.4% |
| Next report (est.)2026-08-11 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$57.9M |
| ROE−55.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+21.6% |
| 1Y+138.3% |
| 3Y−38.8% |
| 5Y−99.4% |
| 10Y−100.0% |
| Since incept. (ann.)−43.0% |
Total return through 2026-07-29 · series begins 2005-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)76.2% |
| Ann. volatility (3Y)194.7% |
| Sharpe (1Y)1.53 |
| Sharpe (3Y)0.42 |
| Max drawdown (1Y)−42.3% |
| Max drawdown (3Y)−94.2% |
| Beta (3Y vs SPY)−0.05 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.0M | $47M | 7.53% | new |
| JANUS HENDERSON GROUP PLC | 1.8M | $29M | 4.63% | +989.3% |
| Venrock Adviser, LLC | 1.7M | $27M | 4.27% | new |
| PERCEPTIVE ADVISORS LLC | 1.4M | $23M | 3.69% | +229.7% |
| Ikarian Capital, LLC | 1.0M | $16M | 2.59% | +5.2% |
| Stonepine Capital Management, LLC | 975,200 | $16M | 2.49% | +8106.0% |
| Logos Global Management LP | 625,000 | $10M | 1.59% | new |
| MORGAN STANLEY | 596,564 | $10M | 1.52% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-12 | −$0.35 | — | $0 | — |
| 2025-09-30 | 2025-11-12 | −$0.40 | — | — | — |
| 2025-06-30 | 2025-08-13 | −$0.27 | — | — | — |
| 2025-03-31 | 2025-05-14 | −$0.28 | — | $0 | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-11 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
